Literature DB >> 2849950

Receptor binding, analgesic and antitussive potency of tramadol and other selected opioids.

H H Hennies1, E Friderichs, J Schneider.   

Abstract

The influence of replacing the phenolic hydroxyl by the methoxy group on opioid receptor binding, analgesic and antitussive action was investigated in the corresponding couples morphine-codeine, hydromorphone-hydrocodone and O-desmethyltramadol (L 235)-tramadol. Binding was studied on rat whole brain membranes (without cerebellum) with the radioligands dihydromorphine (mu-site), ethylketocyclazocine (k-site), D-Ala2-D-Leu5-enkephalin (delta-site) and naloxone (no selective binding). Analgesia (tail flick) and antitussive action (NH3-vapour induced cough) was investigated in rats and ED50 values 10 min after i.v. application were calculated to compare efficacy. All free hydroxyl compounds had higher opioid receptor affinities than the corresponding methoxy derivatives and were more active at the mu-site. The methoxy derivatives codeine and tramadol only had low affinities lacking selectivity towards mu-, kappa-, or delta-binding. Hydrocodone in contrast showed strong and mu-selective binding. The hydroxy compounds had higher analgesic activity than the methoxy congeners and analgesia appeared to correlate with mu-binding affinity. Codeine and hydrocodone were weaker antitussives than the corresponding hydroxy compounds, whereas no significant difference was found between O-desmethyltramadol and tramadol. Only in the tramadol group the methoxy substitution increased antitussive potency in relation to analgesic potency.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2849950

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  71 in total

1.  µ-Opioid receptor activation by tramadol and O-desmethyltramadol (M1).

Authors:  Kouichiro Minami; Yuka Sudo; Kanako Miyano; Robert S Murphy; Yasuhito Uezono
Journal:  J Anesth       Date:  2014-11-14       Impact factor: 2.078

2.  Analgesic and antitussive properties of EM 405.

Authors:  W Englberger; E Friderichs; W Reimann; J Schneider
Journal:  Agents Actions       Date:  1991-01

Review 3.  The role of tramadol in cancer pain treatment--a review.

Authors:  Wojciech Leppert; Jacek Łuczak
Journal:  Support Care Cancer       Date:  2004-11-18       Impact factor: 3.603

4.  Effect of a simple dose-escalation schedule on tramadol tolerability : assessment in the clinical setting.

Authors:  I Tagarro; J Herrera; C Barutell; M C Díez; M Marín; D Samper; C Busquet; M J Rodríguez
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

5.  Effects of human SULT1A3/SULT1A4 genetic polymorphisms on the sulfation of acetaminophen and opioid drugs by the cytosolic sulfotransferase SULT1A3.

Authors:  Ahsan F Bairam; Mohammed I Rasool; Fatemah A Alherz; Maryam S Abunnaja; Amal A El Daibani; Katsuhisa Kurogi; Ming-Cheh Liu
Journal:  Arch Biochem Biophys       Date:  2018-04-26       Impact factor: 4.013

6.  [Not Available].

Authors:  J Olligs; T Stadler
Journal:  Schmerz       Date:  1993-09       Impact factor: 1.107

Review 7.  Pharmacokinetics of opioids in liver disease.

Authors:  I Tegeder; J Lötsch; G Geisslinger
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

8.  Interaction of the central analgesic, tramadol, with the uptake and release of 5-hydroxytryptamine in the rat brain in vitro.

Authors:  B Driessen; W Reimann
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

9.  Pharmacokinetics of tramadol following intravenous and oral administration in male rhesus macaques (Macaca mulatta).

Authors:  K R Kelly; B H Pypendop; K L Christe
Journal:  J Vet Pharmacol Ther       Date:  2014-12-09       Impact factor: 1.786

10.  A comparison of epidural tramadol and epidural morphine for postoperative analgesia.

Authors:  A Baraka; S Jabbour; M Ghabash; A Nader; G Khoury; A Sibai
Journal:  Can J Anaesth       Date:  1993-04       Impact factor: 5.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.